Seppic, a subsidiary of Air Liquide Healthcare, and Botalys, a Belgian start-up specializing in the cultivation of rare and medicinal plants, have signed a research partnership for the co-development of new ingredients for the cosmetics and health markets, as well as distribution contracts in different markets and geographies for Botalys products derived from Ginseng.
To meet a growing demand from the cosmetics and nutraceutical industries for performance and naturalness, Seppic and Botalys are partnering to offer high-quality ingredients to cosmetics and health manufacturers.
Botalys, through an innovative process, has developed a soilless cultivation technology in "vertical farming", to produce ultra-pure and efficient botanical ingredients. Botalys supplies medicinal ingredients and herbs to a multitude of customers and partners in the field of cosmetics, dietary supplements, and pharmacy.
Hannes Moeller, CEO of Seppic, said: "We welcome this new partnership with Botalys. This agreement is fully in line with our corporate strategy to develop natural ingredients from innovative technologies and to distribute exclusive high-performance ingredients for the cosmetics and food supplement markets, while strengthening our focus on the development of new supply chains. »
Pierre-Antoine Mariage, CEO of Botalys, added: "This partnership with Seppic excites the Botalys teams. Our proprietary and innovative precision agriculture technology solves the purity, efficiency and security of supply needs of many rare medicinal plants. This scientific and commercial partnership outlines the enormous potential of this technology for the nutraceutical and cosmetics industry. «
This partnership follows the announcement, on September 29, by Aliad, the venture capital fund of the Air Liquide group, of its investment in Botalys, in line with its strategy of taking positions in impact start-ups. It was accompanied by a co-development and distribution agreement between Seppic and Botalys. Through its international network, Seppic is uniquely positioned to add significant value to Botalys' business development efforts.
